Top upgrades and downgrades on 4/6
Upgrades
• $Invitation Homes Inc(INVH.US$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44)
• $Royalty Pharma(RPRX.US$: Morgan Stanley Upgrades to Overweight from Equalweight - PT $48 (from $46)
• $Synchrony Financial(SYF.US$: Piper Sandler Upgrades to Overweight from Neutral - PT $49 (from $48)
• $Synchrony Financial(SYF.US$: Piper Sandler Upgrades to Overweight from Neutral - PT $49 (from $48)
Downgrades
• $Ameriprise Financial(AMP.US$: Piper Sandler Downgrades to Underweight from Neutral - PT $310 (from $325)
• $Bristol-Myers Squibb(BMY.US$: Morgan Stanley Downgrades to Underweight from Equalweight - PT $64 (from $66)
• $Jazz Pharmaceuticals(JAZZ.US$: Goldman Sachs Downgrades to Neutral from Buy - PT $196 (from $202)
• $Jazz Pharmaceuticals(JAZZ.US$: Goldman Sachs Downgrades to Neutral from Buy - PT $196 (from $202)
• $United Community Banks(UCBI.US$: Raymond James Downgrades to Market Perform from Outperform - PT $42
Initiated
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more
Comment
Sign in to post a comment